Federal Register / Vol. 80, No. 77 / Wednesday, April 22, 2015 / Notices 22553 

Controlled substance Schedule 

Nabilone (7379) ............................ II 

Phencyclidine (7471) .................... II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Diphenoxylate (9170) ................... II 

Ecgonine (9180) ........................... II 

Ethylmorphine (9190) ................... II 

Hydrocodone (9193) ..................... II 

Levorphanol (9220) ...................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Opium, powdered (9639) ............. II 

Levo-alphacetylmethadol (9648) .. II 

Oxymorphone (9652) ................... II 

Fentanyl (9801) ............................ II 

The company plans to import the 

listed controlled substances for sale to 

research facilities for drug testing and 

analysis. 

In reference to drug codes 7360 and 

7370, the company plans to import a 

synthetic cannabidiol and a synthetic 

tetrahydrocannabinol. No other activity 

for this drug code is authorized for this 

registration. 

Dated: April 14, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–09344 Filed 4–21–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: PHARMACORE 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic class, and applicants 

therefore, may file written comments on 

or objections to the issuance of the 

proposed registration in accordance 

with 21 CFR 1301.34(a) on or before 

May 22, 2015. Such persons may also 

file a written request for a hearing on 

the application pursuant to 21 CFR 

1301.43 on or before May 22, 2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODXL, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Request for hearings should be 

sent to: Drug Enforcement 

Administration, Attention: Hearing 

Clerk/LJ, 8701 Morrissette Drive, 

Springfield, Virginia 22152. Comments 

and requests for any hearings on 

applications to import narcotic raw 

material are not appropriate. 72 FR 3417 

(January 25, 2007). 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispenser, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix of subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on August 

29, 2014, Pharmacore, 4180 Mendenhall 

Oaks Parkway, High Point, North 

Carolina 27265 applied to be registered 

as an importer of poppy straw 

concentrate (9670), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import the 

listed controlled substance to 

manufacture bulk controlled substance 

intermediates for sale to its customers. 

Dated: April 14, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–09332 Filed 4–21–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: Cedarburg 

Pharmaceuticals, Inc. 

ACTION: Notice of registration. 

SUMMARY: Cedarburg Pharmaceuticals, 

Inc. applied to be registered as a 

manufacturer of certain basic classes of 

controlled substances. The DEA grants 

Cedarburg Pharmaceuticals, Inc. 

registration as a manufacturer of the 

controlled substances. 

SUPPLEMENTARY INFORMATION: By notice 

dated June 10, 2014, and published in 

the Federal Register on June 17, 2014, 

79 FR 34553, Cedarburg 

Pharmaceuticals, Inc., 870 Badger 

Circle, Grafton, Wisconsin 53024 

applied to be registered as a 

manufacturer of certain basic classes of 

controlled substances. No comments or 

objections were submitted to this notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Cedarburg Pharmaceuticals, Inc. to 

manufacture the basic classes of 

controlled substances is consistent with 

the public interest and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971. The DEA 

investigated the company’s maintenance 

of effective controls against diversion by 

inspecting and testing the company’s 

physical security systems, verifying the 

company’s compliance with state and 

local laws, and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed: 

Controlled substance Schedule 

4-Anilino-N-phenethyl-4-piperidine 

(ANPP) (8333) .......................... II 

Remifentanil (9739) ...................... II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution to its customers. 

Regarding the drug code (8333), the 

company plans to manufacture this 

listed controlled substance for 

commercial sale. 

Dated: April 14, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–09350 Filed 4–21–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Meridian Medical 

Technologies 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic class, and applicants 

therefore, may file written comments on 

or objections to the issuance of the 

proposed registration in accordance 

with 21 CFR 1301.34(a) on or before 

May 22, 2015. Such persons may also 

file a written request for a hearing on 


asabaliauskas on DSK5VPTVN1PROD with NOTICES